AMCP Nexus 2021: Jen Norton, VP & Head of U.S. Value & Access at Amgen Talks Biosimilar Trends and What to Expect in the Next Year

Jen Norton spoke at AMCP Nexus about biosimilar trends of 2021 and what to expect in the next 12 months